Nanoparticles News and Research

RSS

Novel nanoligomer approach to treat severe COVID-19

Researchers discuss the biodistribution and safety of a novel nanoligomer SBCoV207, which was used to targeted miR-2392 in a murine model.

17 Jul 2022

The potential of circular RNA COVID-19 vaccines

A new MedComm study describes the potential use of circular ribonucleic acid COVID-19 vaccines.

17 Jul 2022

Scientists combine robotics with biology to construct biohybrid microrobots

A team of scientists in the Physical Intelligence Department at the Max Planck Institute for Intelligent Systems have combined robotics with biology by equipping E. coli bacteria with artificial components to construct biohybrid microrobots.

15 Jul 2022

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

Small proteins, called chemokines, that direct immune cells toward sites of infection can also form DNA-bound nanoparticles that can induce chronic, dysfunctional immune responses, according to a new study by researchers at Weill Cornell Medicine and Hospital for Special Surgery (HSS).

15 Jul 2022

New anticoagulant platform holds promise as a revolutionary advancement over the current blood thinners

While blood clotting is important to prevent blood loss and for our immunity, coagulation also can cause health issues and even death. Currently, one in four people worldwide dies from diseases and conditions caused by blood clots.

15 Jul 2022

New wireless technology remotely activates specific brain circuits in under one second

A research team led by Rice University neuroengineers has created wireless technology to remotely activate specific brain circuits in fruit flies in under one second.

15 Jul 2022

Researchers use lasers to turn white blood cells into medicinal microrobots

Medicinal microrobots could help physicians better treat and prevent diseases. But most of these devices are made with synthetic materials that trigger immune responses in vivo.

13 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Beyond COVID-19: the potential future applications of mRNA vaccines

Researchers described the production, mechanisms, and potential applications of mRNA vaccines.

6 Jul 2022

Novel inhalable COVID-19 vaccine

A recent study published in the Nature Biomedical Engineering journal illustrated a novel inhalable SARS-CoV-2 vaccine candidate centered on exosomes (Exos) coupled with recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain (RBD).

5 Jul 2022

Novel oral nano-in-micro system provides efficient curcumin delivery to alleviate ulcerative colitis

A new study showed that the newly designed oral nano-in-micro hydrogel delivery platform could be efficiently used to deliver curcumin for the treatment of Ulcerative Colitis.

5 Jul 2022

Filter using whey protein nanofibrils and iron oxyhydroxides nanoparticles catches viruses, including SARS-CoV-2

A recent Swiss study posted to the bioRxiv* preprint server demonstrated that aerosol filters centered on granular protein nanofibrils and iron (Fe) oxyhydroxides nanoparticles could trap virus-containing aerosols.

4 Jul 2022

A gentle, cost-effective method for breast cancer diagnosis

If breast cancer is suspected, doctors carry out a biopsy. However, this is invasive, painful and costly. It also takes several days to get the results.

4 Jul 2022

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

Recently, a team led by Prof. Huang Qing at the Institute of Intelligent Machines, Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS) have reported the fabrication of ultrasensitive biosensors based on Surface-enhanced Raman Spectroscopy (SERS) to detect the cancer metastasis related programmed death ligand (PD-L1) biomarker.

1 Jul 2022

New antibody-based method for SARS-CoV-2 detection does not require a blood sample

Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over. A key challenge in limiting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is identifying infected individuals.

1 Jul 2022

Mosaic-8 RBD-nanoparticles show promise against current and future SARS-CoV-2 variants

A recent study posted to the bioRxiv* preprint server supports using mosaic sarbecovirus receptor-binding domain (RBD)-nanoparticles to discover therapeutic pan-variant and pan-sarbecovirus monoclonal antibodies (mAbs) and to induce mAbs by vaccination.

30 Jun 2022

Nanoparticles can be triggered to release anti-cancer microRNA using an alternating magnetic field

Study shows that nanoparticles release an anti-cancer microRNA inside lung cancer cells when stimulated using an alternating magnetic field.

30 Jun 2022

Proteins in the eye may predict which macular degeneration patients need life-long treatment

In a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision or if they can be safely weaned off the treatments.

29 Jun 2022

Lipid-peptide nanocomplexes offer new mRNA platform

A new paper reports the methodical development of lipid-peptide nanocomplexes as a delivery vehicle for messenger ribonucleic acid molecules to the tumor cell, in vitro and in vivo.

27 Jun 2022

Nanoparticles News and Research

Novel nanoligomer approach to treat severe COVID-19

The potential of circular RNA COVID-19 vaccines

Scientists combine robotics with biology to construct biohybrid microrobots

Chemokine-DNA nanoparticles can induce chronic, dysfunctional immune responses

New anticoagulant platform holds promise as a revolutionary advancement over the current blood thinners

New wireless technology remotely activates specific brain circuits in under one second

Researchers use lasers to turn white blood cells into medicinal microrobots

Universal influenza B vaccine confers robust and sustained cross-immune protection

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Beyond COVID-19: the potential future applications of mRNA vaccines

Novel inhalable COVID-19 vaccine

Novel oral nano-in-micro system provides efficient curcumin delivery to alleviate ulcerative colitis

Filter using whey protein nanofibrils and iron oxyhydroxides nanoparticles catches viruses, including SARS-CoV-2

A gentle, cost-effective method for breast cancer diagnosis

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

New antibody-based method for SARS-CoV-2 detection does not require a blood sample

Mosaic-8 RBD-nanoparticles show promise against current and future SARS-CoV-2 variants

Nanoparticles can be triggered to release anti-cancer microRNA using an alternating magnetic field

Proteins in the eye may predict which macular degeneration patients need life-long treatment

Lipid-peptide nanocomplexes offer new mRNA platform

How to solve the hidden bottleneck in lipid nanoparticle development eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News